A growing number of studies have identified the LCN2 gene as crucial for various tumor-related processes, including tumorigenesis, tumor progression, and tumor resistance to therapies such as radiotherapy, chemotherapy, endocrine therapy, and targeted therapy (5–12). This evidence concerns the gene LCN2 and neoplasm.